HomeCompareENPRF vs CHD

ENPRF vs CHD: Dividend Comparison 2026

ENPRF yields 38461.54% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ENPRF wins by $3.5047453194285434e+22M in total portfolio value
10 years
ENPRF
ENPRF
● Live price
38461.54%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.5047453194285434e+22M
Annual income
$34,869,111,860,403,882,000,000,000,000.00
Full ENPRF calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — ENPRF vs CHD

📍 ENPRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodENPRFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ENPRF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ENPRF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENPRF
Annual income on $10K today (after 15% tax)
$3,269,230.77/yr
After 10yr DRIP, annual income (after tax)
$29,638,745,081,343,300,000,000,000,000.00/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, ENPRF beats the other by $29,638,745,081,343,300,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENPRF + CHD for your $10,000?

ENPRF: 50%CHD: 50%
100% CHD50/50100% ENPRF
Portfolio after 10yr
$1.7523726597142717e+22M
Annual income
$17,434,555,930,201,941,000,000,000,000.00/yr
Blended yield
99.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

ENPRF
No analyst data
Altman Z
-47.1
Piotroski
2/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENPRF buys
0
CHD buys
0
No recent congressional trades found for ENPRF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricENPRFCHD
Forward yield38461.54%1.27%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$3.5047453194285434e+22M$26.4K
Annual income after 10y$34,869,111,860,403,882,000,000,000,000.00$1,292.51
Total dividends collected$3.5035733915069485e+22M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ENPRF vs CHD ($10,000, DRIP)

YearENPRF PortfolioENPRF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$3,856,854$3,846,153.85$10,856$156.32+$3.85MENPRF
2$1,390,486,951$1,386,360,117.24$11,811$195.24+$1390.48MENPRF
3$468,605,187,973$467,117,366,935.83$12,883$244.38+$468605.18MENPRF
4$147,625,030,644,438$147,123,623,093,306.88$14,091$306.64+$147625030.63MENPRF
5$43,474,277,650,870,744$43,316,318,868,081,190.00$15,463$385.88+$43474277650.86MENPRF
6$11,968,270,987,896,644,000$11,921,753,510,810,212,000.00$17,033$487.17+$11968270987896.63MENPRF
7$3,080,100,013,539,240,000,000$3,067,293,963,582,191,000,000.00$18,843$617.36+$3080100013539240.00MENPRF
8$741,038,587,172,289,600,000,000$737,742,880,157,802,600,000,000.00$20,947$785.72+$741038587172289664.00MENPRF
9$166,674,143,814,537,900,000,000,000$165,881,232,526,263,560,000,000,000.00$23,419$1,004.91+$166674143814537904128.00MENPRF
10$35,047,453,194,285,434,000,000,000,000$34,869,111,860,403,882,000,000,000,000.00$26,350$1,292.51+$3.5047453194285434e+22MENPRF

ENPRF vs CHD: Complete Analysis 2026

ENPRFStock

Current Water Technologies Inc. develops environmental technologies in Canada, Australia, and the United States. It operates through two segments, Current Water and Pumptronics. The company provides patented and proprietary technologies for the treatment of wastewater and drinking water that are contaminated by metals or nutrients, such as arsenic and nitrate/ammonia associated with the mining, metal processing, chemical, agricultural, municipal, and waste management sectors; and for the recovery of nickel and other valuable metals from waste mill sulphide tailings associated with the mining sector. Its technologies include electro-static deionization, a electrochemical process that lowers the concentration of total dissolved solids in water; ammonia removal technology, a technology used for the removal of dissolved ammonia from industrial and municipal water, including wastewater, storm water, sewage effluent, and mine waste water; NitrEL system, an electrochemical water treatment process that reduces nitrate concentrations in contaminated drinking water, groundwater, and industrial process wastewater streams; AmdEl, an electrochemical system that prevents the oxidation of sulphide minerals in tailings or waste rock; and ExtrEL for the recovery of metals from sulphide tailings and ore. The company was formerly known as ENPAR Technologies Inc. and changed its name to Current Water Technologies Inc. in January 2018. Current Water Technologies Inc. was incorporated in 1996 and is headquartered in Guelph, Canada.

Full ENPRF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this ENPRF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENPRF vs SCHDENPRF vs JEPIENPRF vs OENPRF vs KOENPRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.